Clinical Trials Logo

Cartilage Degeneration clinical trials

View clinical trials related to Cartilage Degeneration.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05999266 Completed - Clinical trials for Rheumatoid Arthritis

The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis

Start date: September 28, 2023
Phase:
Study type: Observational [Patient Registry]

The knee pain status of the patients who are followed in the rheumatology special branch of the Physical Medicine and Rehabilitation Outpatient Clinic and who meet the inclusion criteria will be questioned. In patients with or without knee pain, the cartilage thickness measurement of the knee joint will be measured from 3 points by ultrasound. At the same time, Quadriceps and Hamstring muscle thickness measurements of the patients will be made from the midpoints where the muscle thickness is the highest. The physician who performed the ultrasonographic measurements of the knee pain status of the patients does not know.

NCT ID: NCT04486534 Completed - Clinical trials for Cartilage Degeneration

The Assessment of Talar Cartilage in Patients With Unilateral Traumatic Transtibial Amputation

Start date: July 26, 2020
Phase:
Study type: Observational

Increased risk of osteoarthritis (OA) has been previously demonstrated in patients with lower limb amputation. Although there are many studies on knee joint of intact limb of amputees in the literature, the number of studies on intact foot and ankle is extremely limited. The primary aim of the study is to compare the intact talar cartilage, tibialis anterior and gastrocnemius muscle thickness measurements of traumatic unilateral transtibial amputee patients with that of healthy individuals using ultrasound. The secondary aim is to investigate the relationship between cartilage and muscle thickness measurements with clinical parameters.

NCT ID: NCT04454164 Completed - Knee Osteoarthritis Clinical Trials

Platelet Rich Plasma Injection for Knee Osteoarthritis

Start date: June 1, 2018
Phase: Early Phase 1
Study type: Interventional

The research questions of this study are; 1. Is platelet rich plasma (PRP) treatment effective in knee osteoarthritis (OA)? 2. What are the indications for PRP treatment? 3. Which patients are the most suitable for the PRP treatment method? 4. How does age, Body Mass Index (BMI), lower extremity mechanical axis angle and OA stages affect the success of the PRP treatment? 5. Is there any advantage of multiple PRP doses? 6. What is the therapeutic effect of placebo? This study was designed to find answers of these questions. The hypotheses of this study are; "PRP treatment is more effective than placebo; PRP treatment effectiveness decreases with age and advanced stages of OA; BMI is a factor that negatively affects the treatment effectiveness of the PRP; as the mechanical axis angle of the lower limb increases, it will adversely affect the effectiveness of PRP therapy; multiple dose of PRP affects the effectiveness and duration of PRP as positively compared to single dose of PRP". The primary purpose of this study; to prove the effectiveness of PRP treatment on knee pain and functions in patients with knee OA by comparing it with the placebo control group. Secondary purposes of this study; to understand the effect of age, BMI, OA grade and lower limb mechanical axis angle on PRP effectiveness. This study, designed as a randomized, double-blind and placebo control group, with a high level of scientific evidence. Thus, it will be scientifically possible to find answers to the investigators research questions and to prove the investigators hypothesis.

NCT ID: NCT03850080 Completed - Knee Osteoarthritis Clinical Trials

Autologous Conditioned Serum: Functional and Clinical Results

Start date: October 6, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study was to investigate the potential ability of autologous conditioned serum (ACS) to decrease the pain and improve the joint functionality in patients affected by knee osteoarthritis (OA).

NCT ID: NCT03072147 Completed - Knee Osteoarthritis Clinical Trials

Teriparatide as a Chondroregenerative Therapy in OA

Start date: May 1, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate teriparatide (TP) as a chondroregenerative therapy for human knee osteoarthritis (OA). The central hypothesis to be tested is that TP supports structural modification of the joint and improves biomarker, functional and patient-reported measures of knee OA.

NCT ID: NCT01418755 Completed - Clinical trials for Cartilage Degeneration

Study of Platelet-rich Plasma in Treating Patients With Tibiofemoral Cartilage Degeneration

Start date: January 2009
Phase: N/A
Study type: Interventional

Recently an articular cartilage repair has been given much attention in the orthopaedic field. Cartilage regeneration capacity is very limited. Optimal approach seems to be a delivery of natural growth factors. Autologous platelet-rich plasma (PRP) contains proliferative and chemoattractant growth factors. The objective of the present study was to determine if PRP can increase tibiofemoral cartilage regeneration and improve knee function.